Zhao Xiaoyi X - OmicsDI

Show results for

Proteomics (2)
Metabolomics (1)

Organisms

Homo sapiens (2)

Repository

iProX (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)

Publication Date

2026 (2)
2024 (1)

CHEBI ID

CHEBI:229940 (1)
CHEBI:190147 (1)
CHEBI:39745 (1)
CHEBI:136372 (1)
CHEBI:229945 (1)
CHEBI:141366 (1)
CHEBI:170316 (1)
CHEBI:190161 (1)
CHEBI:137332 (1)
CHEBI:88434 (1)
CHEBI:190154 (1)
CHEBI:190169 (1)
CHEBI:88859 (1)
CHEBI:190153 (1)
CHEBI:171009 (1)
CHEBI:89977 (1)
CHEBI:190167 (1)
CHEBI:89403 (1)
CHEBI:89928 (1)
CHEBI:171363 (1)
CHEBI:184279 (1)
CHEBI:170854 (1)
CHEBI:178112 (1)
CHEBI:175330 (1)
CHEBI:190165 (1)
CHEBI:190163 (1)
CHEBI:134076 (1)
CHEBI:89156 (1)
CHEBI:229944 (1)
CHEBI:190157 (1)

Metabolite Name

Bilobalide A (1)
3,4,5,6-tetrahydroxyoxane-2-carboxylic acid (1)
(9xi,10xi,12xi)-9,10-Dihydroxy-12-octadecenoic acid (1)
D-2,3-Dihydroxypropanoic acid (1)
Isohyodeoxycholic acid (1)
D-Xylitol (1)
[10]-Dehydrogingerdione (1)
Alpha-CEHC (1)
2(3H)-Benzothiazolethione (1)
O-Phosphothreonine (1)
P-Cresol sulfate (1)
D-Malic acid (1)
3-Methoxy-4-hydroxyphenylethyleneglycol sulfate (1)
(R)-lipoic acid (1)
(10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid (1)
9,10-epoxyoctadecanoic acid (1)
Phenobarbital (1)
[8]-Dehydrogingerdione (1)
2-Ketohexanoic acid (1)
2-Ethyl-2-Hydroxybutyric acid (1)
16-Methylheptadecanoic acid (1)
9-Decenoic acid (1)
Erythrono-1,4-lactone (1)
10E,12Z-Octadecadienoic acid (1)
Ethyl hexadecanoate (1)
Halosulfuron-methyl (1)
Carbadox (1)
8,15-DiHETE (1)
8-isoprostaglandin E2 (1)
Trans-urocanate (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Clinical efficacy of Yiqi Yangxue formula on knee osteoarthritis and unraveling therapeutic mechanism through plasma metabolites in rats.

OBJECTIVE: To observe the clinical efficacy and safety of Yiqi Yangxue formula (YQYXF) on knee osteoarthritis (KOA), and to explore the underlying therapeutic mechanism of YQYXF through endogenous differential metabolites and their related metabolic pathways.

METHOD...

2024-03-25 | MTBLS5667 | MetaboLights

CRL4AMBRA1 mediated progesterone receptor degradation drives progestin resistance and represents a therapeutic vulnerability in endometrial cancer

AMBRA1 ubiquitinates PR to ptomote progestin resistance in endometrial cancer

ORGANISM(S): Homo Sapiens

2026-01-04 | PXD072640 |